David Sinclair's lab used AI to screen billions of compounds and created a five-cent pill that reversed aging in skin cells from 92-year-old donors within six weeks. They're launching human trials soon as part of an XPRIZE competition.
Chapters
We're in the lab using AI and visualization, machine learning, to tell us whether cells from old humans, 92-year-olds, their skin cells can be reversed back to a 20-year-old. We developed this current technology that's going into humans shortly. Since 2017, we've been working in my lab on bringing the price down, finding new ways. And the cheapest is a small molecule. Small molecule can be made potentially for, you know, a few cents a pill. And we find that the dosing, even with ER100, which is the viral candidate drug going into humans, you only need 6 weeks. So, you know, in 6 weeks, some doctor may even know the answer whether this works in humans. These chemicals could be very cheap. We've been working on them. We've been using mostly artificial intelligence to screen billions of molecules in silico. I can say we already have a proof of concept. Which is a cocktail of molecules that some of which we published on already a couple of years ago, and those we hope to put into a clinical trial into humans within the next couple of months as part of our XPRIZE competition.